#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13176	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2058	636.9	0	.	n	.	0	T1157C	SNP	1157	1157	T	1380	1380	C	742	C,T,G	610,1,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13176	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2058	636.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1673	1673	T	772	T,C	703,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13176	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2058	636.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1407	1407	C	775	C	697	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13176	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2058	636.9	0	HET	.	.	.	A337G	.	337	337	A	560	560	A	700	A,G	467,158	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23706	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3677	643.4	0	.	n	.	0	C1623T	SNP	1623	1623	C	2078	2078	T	779	T,C	686,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23706	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3677	643.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2426	2426	C	724	C,T	658,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23706	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3677	643.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2500	2500	A	727	A	675	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23706	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3677	643.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3052	3052	C	759	C	706	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1690	folP	855	855	100.0	folP.l15.c4.ctg.1	1513	111.2	1	SNP	p	R229S	1	.	.	685	687	AGC	955	957	AGC	152;152;155	A;G;C	144;141;143	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4930	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3300	149.0	0	.	p	.	0	M250I	NONSYN	748	750	ATG	1041	1043	ATA	141;138;137	A;T;A	131;130;129	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4930	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3300	149.0	1	SNP	p	S91F	0	.	.	271	273	TCC	564	566	TCC	176;176;176	T;C;C	156;158;157	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4930	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3300	149.0	1	SNP	p	D95G	0	.	.	283	285	GAC	576	578	GAC	167;168;169	G;A;C	144;146;146	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4930	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3300	149.0	1	SNP	p	D95N	0	.	.	283	285	GAC	576	578	GAC	167;168;169	G;A;C	144;146;146	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	1464	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1313	111.0	1	SNP	p	G45D	1	.	.	133	135	GAC	436	438	GAC	191;192;192	G;A;C	177;174;177	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	752	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	906	82.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4212	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3034	138.3	1	SNP	p	D86N	0	.	.	256	258	GAC	621	623	GAC	141;142;143	G;A;C	123;121;125	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4212	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3034	138.3	1	SNP	p	S87R	0	.	.	259	261	AGT	624	626	AGT	145;145;145	A;G;T	127;128;127	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4212	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3034	138.3	1	SNP	p	S87W	0	.	.	259	261	AGT	624	626	AGT	145;145;145	A;G;T	127;128;127	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4212	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3034	138.3	1	SNP	p	S87I	0	.	.	259	261	AGT	624	626	AGT	145;145;145	A;G;T	127;128;127	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4212	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3034	138.3	1	SNP	p	S88P	0	.	.	262	264	TCC	627	629	TCC	148;151;151	T;C;C	130;132;132	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3836	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2578	148.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1499	1501	GGC	193;192;191	G;G;C	182;180;178	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	3780	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2409	156.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1271	1273	GCA	220;223;227	G;C;A	197;198;205	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3780	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2409	156.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1274	1276	ATC	229;228;229	A;T;C	203;204;205	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3780	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2409	156.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1286	1288	GTG	220;222;222	G;T;G	195;196;197	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3780	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2409	156.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1286	1288	GTG	220;222;222	G;T;G	195;196;197	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3780	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2409	156.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1790	1792	ACC	194;192;189	A;C;C	168;173;172	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3780	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2409	156.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1844	1846	GCG	184;181;181	G;C;G	158;150;155	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3780	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2409	156.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1844	1846	GCG	184;181;181	G;C;G	158;150;155	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3780	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2409	156.2	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1967	1969	GGT	167;167;167	G,A;G;T,C	153,1;155;152,1	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3780	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2409	156.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1976	1978	GGC	161;157;157	G;G;C	146;143;143	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3780	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2409	156.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1994	1996	CCG	160;160;160	C,G;C;G	113,1;129;119	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5192	ponA	2397	2397	99.83	ponA.l15.c30.ctg.1	2936	176.1	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1426	1428	ACG	167;167;169	A;C;G	150;153;155	.	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5192	ponA	2397	2397	99.83	ponA.l15.c30.ctg.1	2936	176.1	0	.	p	.	0	A471T	NONSYN	1411	1413	GCA	1714	1716	ACA	194;194;192	A;C;A	164;168;169	.	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5192	ponA	2397	2397	99.83	ponA.l15.c30.ctg.1	2936	176.1	0	.	p	.	0	T692M	NONSYN	2074	2076	ACG	2377	2379	ATG	178;179;178	A;T;G	137;146;147	.	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5192	ponA	2397	2397	99.83	ponA.l15.c30.ctg.1	2936	176.1	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1564	1566	CTG	177;178;176	C;T;G	153;155;154	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2000	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1635	121.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	471	471	C	149	C	125	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2388	porB1b	1041	1041	97.42	porB1b.l15.c4.ctg.1	1627	146.2	0	.	p	.	0	G46S	NONSYN	136	138	GGC	423	425	AGC	203;207;209	A;G;C	189;193;194	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2388	porB1b	1041	1041	97.42	porB1b.l15.c4.ctg.1	1627	146.2	0	.	p	.	0	S54A	NONSYN	160	162	TCC	447	449	GCC	213;214;216	G;C;C	186;186;189	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2388	porB1b	1041	1041	97.42	porB1b.l15.c4.ctg.1	1627	146.2	0	.	p	.	0	K120D	NONSYN	358	360	AAG	645	647	GAC	192;193;195	G;A,G;C	178;174,1;178	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2388	porB1b	1041	1041	97.42	porB1b.l15.c4.ctg.1	1627	146.2	0	.	p	.	0	A151V	NONSYN	451	453	GCA	738	740	GTA	221;222;221	G;T;A	206;206;204	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2388	porB1b	1041	1041	97.42	porB1b.l15.c4.ctg.1	1627	146.2	0	.	p	.	0	A213L	NONSYN	637	639	GCA	924	926	TTA	175;176;177	T;T;A	164;167;166	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2388	porB1b	1041	1041	97.42	porB1b.l15.c4.ctg.1	1627	146.2	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1044	1046	CAA	152;151;149	C;A;A	144;145;144	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2388	porB1b	1041	1041	97.42	porB1b.l15.c4.ctg.1	1627	146.2	0	.	p	.	0	.	INDELS	760	761	AC	1048	1051	ATCA	150;150;148;146	A;T;C;A	143;143;142;141	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2388	porB1b	1041	1041	97.42	porB1b.l15.c4.ctg.1	1627	146.2	0	.	p	.	0	.	MULTIPLE	764	765	AC	1056	1058	GTG	139;141;143	G;T;G	132;133;135	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2388	porB1b	1041	1041	97.42	porB1b.l15.c4.ctg.1	1627	146.2	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1062	1064	GAT	143;142;144	G,T,A;A;T	136,1,1;137;140	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2388	porB1b	1041	1041	97.42	porB1b.l15.c4.ctg.1	1627	146.2	0	.	p	.	0	A270V	NONSYN	808	810	GCG	1101	1103	GTG	182;180;180	G;T;G	170;167;167	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2388	porB1b	1041	1041	97.42	porB1b.l15.c4.ctg.1	1627	146.2	0	.	p	.	0	L277V	NONSYN	829	831	TTA	1122	1124	GTA	181;181;182	G;T;A	166;167;168	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2388	porB1b	1041	1041	97.42	porB1b.l15.c4.ctg.1	1627	146.2	0	.	p	.	0	S290T	NONSYN	868	870	TCT	1161	1163	ACT	203;204;208	A;C;T	182;183;186	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2388	porB1b	1041	1041	97.42	porB1b.l15.c4.ctg.1	1627	146.2	0	.	p	.	0	H292D	NONSYN	874	876	CAT	1167	1169	GAT	205;203;206	G,A;A;T	185,1;183;188	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2388	porB1b	1041	1041	97.42	porB1b.l15.c4.ctg.1	1627	146.2	0	.	p	.	0	Y296H	NONSYN	886	888	TAC	1179	1181	CAC	192;194;190	C;A;C	171;173;171	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9842	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4850	202.5	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2048	2050	CAT	195;198;200	C;A;T	169;173;175	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	956	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	931	102.2	1	SNP	p	V57M	1	.	.	169	171	ATG	445	447	ATG	213;214;215	A;T;G	192;191;195	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	27	14438	tetM	1920	1920	100.0	tetM.l15.c4.ctg.1	2604	553.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
